Therefore, this cross-sectional study aimed to investigate the direct association of central sensitivity to thyroid hormone (evaluated by TFQI) and peripheral sensitivity to thyroid hormone (evaluated by FT3/FT4) with dyslipidemia and NAFLD, trying to overcome current contradictions about the association between circulating thyroid hormone levels and hepatic alterations. This evidence concerns the gene TG and metabolic syndrome.